Chongqing, China

Xiaohai Tang

This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Sichuan Yingrui Pharmaceutical Technology Company. Active years: 2022-2023.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.4

ph-index = 1


Location History:

  • Chongqing, CN (2022)
  • Sichuan, CN (2023)

Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Xiaohai Tang

Introduction

Xiaohai Tang is an inventor based in China, known for his contributions in the pharmaceutical sector. Currently employed at Chongqing Lummy Pharmaceutical Co., Ltd., Xiaohai has dedicated his career to advancing healthcare through innovative solutions.

Latest Patents

As of now, Xiaohai Tang holds no patents. However, his work at Chongqing Lummy Pharmaceutical Co., Ltd. indicates a commitment to the research and development of pharmaceutical products that could potentially lead to innovative inventions in the future.

Career Highlights

During his career, Xiaohai has been involved in several projects that emphasize the importance of pharmaceutical research and development. His work aligns with the goals of his company, aiming to improve health outcomes through effective medication.

Collaborations

Xiaohai Tang collaborates with his coworker, Xin Song, to drive various initiatives within Chongqing Lummy Pharmaceutical Co., Ltd. Their teamwork underscores the significance of collaboration in the innovation process, particularly in the pharmaceutical field.

Conclusion

While Xiaohai Tang may not yet have patents to his name, his role in a prominent pharmaceutical company showcases his potential for future innovations. With ongoing projects and collaborations, he remains a noteworthy contributor to the industry, and it will be interesting to see how his career evolves and what inventions may come to fruition.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…